Top Companies in Wearable Healthcare Devices

The global wearable healthcare devices market is projected to reach USD 75.98 billion by 2030 from USD 45.29 billion in 2025, at a CAGR of 10.9% during the forecast period. Wearable healthcare devices play a crucial role in enhancing personal health monitoring, chronic disease management, and preventive care. These devices include smartwatches, fitness trackers, wearable patches, and smart clothing, all equipped with advanced sensors that collect physiological data such as heart rate, blood oxygen levels, and sleep patterns. Widely adopted across home healthcare, remote patient monitoring, and general wellness settings, these devices promote proactive health management and improved patient engagement. Their integration with mobile apps and cloud platforms allows for real-time data access, supporting timely medical interventions and adherence to care plans. Moreover, wearable healthcare devices are designed in alignment with industry standards and regulatory frameworks, ensuring safety, reliability, and broad applicability across diverse user groups—from fitness enthusiasts to individuals managing chronic conditions.

Notable companies in this market include Apple Inc. (US), Samsung (South Korea), Abbott (US), DexCom, Inc. (US), Fitbit Inc. (US), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Garmin Ltd. (US), GE HealthCare (US), Masimo (US), Boston Scientific Corporation (US), Biotricity (US), iRhythm Technologies, Inc. (US), and CONTEC MEDICAL SYSTEMS CO., LTD. (China), among others. The leading companies in the market focus on higher sales, product launches, and product approvals.

To know about the assumptions considered for the study download the pdf brochure

Apple Inc. (US) is a leading player in the global wearable healthcare devices market, with a strong presence across North America, Europe, Latin America, and the Middle East & Africa. The company consistently strengthens its competitive edge by expanding its product portfolio and making strategic investments in innovation. Apple has significantly increased its R&D spending over the years—investing USD 26.25 billion in 2022, USD 29.92 billion in 2023, and USD 31.37 billion in 2024—underscoring its commitment to developing cutting-edge technologies and diversifying into emerging markets. Apple primarily adopts organic growth strategies to sustain its leadership in the wearable healthcare space. In July 2025, the company launched the Apple Watch Series 10, its thinnest and most advanced model to date. The device features the largest display in the Apple Watch lineup, new sleep apnea detection capabilities, water depth and temperature sensing, faster charging, and AI-powered health and fitness insights integrated with watchOS 11. These innovations further solidify Apple's positioning as a front-runner in personal health monitoring and reinforce its commitment to delivering comprehensive wellness solutions through wearable technology.

Samsung (South Korea) is a global technology leader engaged in the design and manufacturing of consumer electronics, semiconductors, and communication devices. The company operates through four main business segments: DX (Device eXperience), DS (Device Solutions), SDC (Samsung Display), and Harman. Wearable devices, including smartwatches and fitness trackers, are offered under the DX division. Samsung is a prominent player in the wearable healthcare devices market, particularly in the smartwatch and fitness tracker segments. The company's competitive advantage stems from its strong brand presence, broad global customer base, and advanced sensor integration capabilities. Its Galaxy Watch series has been effectively positioned as a multifunctional health monitoring tool, featuring clinical-grade capabilities such as sleep apnea detection, heart rate monitoring, and electrocardiogram (ECG) functionality. These features have reinforced Samsung's status as a key innovator in the consumer healthcare wearables space.

Abbott (US) is a global healthcare company engaged in the discovery, development, and manufacturing of a broad range of healthcare solutions. The company operates through four primary business segments: Pharmaceuticals, Diagnostics, Nutrition, and Medical Devices. Its wearable healthcare offerings are primarily delivered through the Medical Devices segment, particularly within the Diabetes Care division, which provides continuous glucose monitoring (CGM) systems, test strips, sensors, data management tools, and related accessories for diabetes management. Abbott’s strong international presence and the essential role of its products have positioned it as a key player in improving healthcare access across both developed and emerging markets. The company places a strong focus on research and development to drive innovation and maintain its competitive advantage. In 2024, Abbott invested USD 2.84 billion in R&D, underscoring its commitment to delivering advanced, high-quality wearable healthcare solutions.

Market Ranking:

The wearable healthcare devices market is dominated by key players such as Apple Inc. (US), Samsung (South Korea), Abbott (US), DexCom, Inc. (US), and Fitbit Inc. (US), who together account for approximately 70–75% of the total market share. Apple Inc. maintains its leadership through a robust product ecosystem, continuous innovation in health-tracking features, and strong brand loyalty. Samsung leverages its advanced sensor technology and global presence to strengthen its position, especially in the smartwatch segment. Abbott stands out with its clinically validated solutions, particularly in diabetes care, supported by strong R&D and global reach. DexCom, Inc. leads in the continuous glucose monitoring (CGM) space with FDA-cleared systems tailored for real-time diabetes management. Fitbit Inc., backed by Alphabet Inc. (US), holds a solid share in fitness-focused devices and continues to expand its health monitoring capabilities.

The market is highly competitive, driven by rapid technological innovation, increasing regulatory engagement, and a growing emphasis on remote health and preventive care.

Related Reports:

Wearable Healthcare Devices Market by Product (Trackers, Smartwatch, Patches), Type (Diagnostic (Vital Sign, ECG, Glucose), Therapeutic (Pain, Insulin)), Grade (Consumer, Clinical), Channel (Online, Pharmacy), Application (RPM) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com